Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Oxabact (OC5) for efficacy and safety in patients with primary hyperoxaluria on dialysis has completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria

Drugs mentioned

• Oxabact

Snippet

Sponsor: OxThera | Conditions: Primary Hyperoxaluria | Phase 2 | Status: COMPLETED | Results posted: 2021-12-09